The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman

Journal of Sexual Medicine

Volumn 4, Issue 5, 2007, Pages 1209-1213

  Glina, Sidney ^a   Gelbard, Martin K ^b   Akkus, Emre ^c   Jordan, Gerald H ^d   Levine, Laurence A ^e  

^a Instituto H Ellis   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ISTANBUL UNIVERSITY   (Turkey)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPIONITRILE; 4 AMINOBENZOATE POTASSIUM; ALPHA TOCOPHEROL; COLLAGENASE; CORTICOSTEROID; INTERFERON; LIDOCAINE; PARATHYROID HORMONE; PLACEBO; VERAPAMIL;

ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; CORPUS CAVERNOSUM; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUPUYTREN CONTRACTURE; ECCHYMOSIS; HUMAN; INJECTION PAIN; PAIN ASSESSMENT; PENIS ERECTION; PENIS INJURY; PEYRONIE DISEASE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; TUNICA ALBUGINEA;

EID: 34548319592     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00581.x     Document Type: Article

References (17)

1. Gelbard MK, Lindner A, Kaufman JJ. The use of collagenase in the treatment of Peyronie's disease. J Urol 1985;134:280.
2. Gelbard MK, Walsh R, Kaufman JJ. Collagenase for Peyronie's disease: Experimental studies. Urol Res 1982;10:135-7.
3. Levine, LA, ed. Peyronies's disease - A guide to clinical management. New Jersey: Humana Press Totowa; 2007.
4. Starkweather KD, Lattuga S, Hurst LC, Badalamente MA, Guilak F, Sampson SP, Dowd A, Wisch D. Collagenase in the treatment of Dupuytren's disease: An in vitro study. J Hand Surg [Am] 1996;21:490-5.
5. Gelbard M. Peyronie's disease. In: Das, S, Hashmat A, eds. The Penis. Philadelphia: Lea & Febiger;1993:3.
6. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg 2000;25A:629-36.
7. Levine L, Merrick P, Lee R. Intralesional verapamil injection for the treatment of Peyronie's disease. J. Urol 1994;151:1522-4.
8. Pryor JP, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Priapism. In: Lue TF, Rosen R, Basson R, Guiliano F, Montorsi F, eds. WHO 2nd consultation sexual and erectile dysfunction. Paris: Health Publications; 2004:383-408.
9. Teasley G. Peyronie's disease: The new approach. J Urol 1954;105:523.
10. Morales A, Bruce AW. The treatment of Peyronie's disease with parathyroid hormone. J Urol 1975;114: 901-2.
11. Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of Verapamil for Peyronie's disease. J Urol 2002;168:621-5; discussion 625-6.
12. Hakim LS, Khater U. Non-surgical management of Peyronie's curvature: Experience using intralesional Intron-A therapy. J Sex Med 2004;1:51-72.
13. Levine L, Greenfield JM. Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 2003;15 (5 Suppl): S103-S12.
14. Ohebshalom M, Mulhall J, Guhring P, Parker M. Measurement of penile curvature in Peyronie's disease patients: Comparison of three methods. J Sex Med 2007;4:199-203.
15. Del Carlo M, Levine L, Cole A. Stimulation increases the endogenous production of matrix metalloproteinases in Peyronie's fibroblasts. J Sex Med 2007;(suppl 1): 67.
16. Deveci S, Hopps CV, O'Brien K, Parker M, Guhring P, Mulhall JP. Defining the clinical characteristics of Peyronie's disease in young men. J Sex Med 2007;4:485-90.
17. Domes T, De Young L, O'Gorman DB, Gan BS, Bella AJ, Brock G. Is there a role for proteomics in Peyronie's disease? J Sex Med 2007; 4: 867-77.